Sells medicated feed additives, other assets (Il Sole 24 Ore Radiocor) - New York, 29 Apr - Zoetis, a US producer of medicine and vaccinations for pets and livestock, said that it has entered into a definitive agreement to its sell medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for 350 million dollars.

This transaction is expected to be complete in the second half of 2024, it added.

The acquired product portfolio, which generated approximately 400 million dollars in revenue in 2023, is comprised of more than 37 product lines that are sold in approximately 80 countries. Also included in the agreement are six manufacturing sites, four in the US, one in Italy and one in China. More than 300 Zoetis colleagues who support manufacturing, distribution and commercial activities are expected to transition to Phibro Animal Health, it said.

AAA-Web

(RADIOCOR) 29-04-24 19:31:07 (0631) 5 NNNN